NCT04347382View on ClinicalTrials.gov

Honey & Nigella Sativa Trial Against COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Coronavirus InfectionSars-CoV2
Interventions
DRUG

Honey

1gm/Kg/Day

DRUG

Nigella Sativa / Black Cumin

80mg/Kg/day

DRUG

Placebos

Empty capsule with 250ml of distilled water

Trial Locations (2)

54600

Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore

Services Institute of Medical Sciences, Services Hospital, Lahore

All Listed Sponsors
lead

Sohaib Ashraf

OTHER

NCT04347382 - Honey & Nigella Sativa Trial Against COVID-19 | Biotech Hunter | Biotech Hunter